News

Fierce Biotech11d
Moderna's flu/COVID combination vax hit by deprioritization, FDA delay as R&D spend sinks 19%
Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...
Moderna study shows immune response in older adults for a combo flu and COVID-19 shot
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
U.S. News & World Report4d
Moderna's Combo Flu and COVID Shot Shows Promise
THURSDAY, May 8, 2025 (HealthDay News) — A new vaccine that combines flu and COVID ... Moderna said it now expects that approval of the shot may not come until 2026. “I agree in this case ...
Moderna says FDA has been constructive, but delays flu/COVID shot
Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...
KWCH3d
Moderna study shows immune response in older adults for a new combo flu and COVID-19 shot
Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 ... agree in this case with the FDA ...